|
|
 |
|
Viewing report
|
|
|
|
Pevion Biotech Ltd - Strategic SWOT Analysis Review
GlobalData, Sep 2011, Pages: 28
Pevion Biotech Ltd - Strategic SWOT Analysis Review
Summary
Pevion Biotech Ltd (Pevion Biotech) is a biopharmaceutical company, engaged in the preclinical and clinical development of vaccines to prevent mucosal infections and cancer. It develops products using its proprietary virosome-based technology platform that are used in the development of prophylactic or therapeutic vaccines. Pevion Biotech develops therapeutic vaccines against breast cancer, candidiasis, respiratory syncytial virus (RSV) and influenza. The product portfolio of the company comprises a range of PEV7, is developed for the treatment of chronic recurrent thrush recurrent vulvovaginal candidiasis (RVVC); PEV3A, is the product candidate for the treatment of Malaria, being jointly developed with Mymetics Corporation; PEV6, breast cancer vaccine; and PEV4, a prophylactic respiratory syncytial virus (RSV) vaccine. It has partnered with several pharmaceutical companies and research institutions in the area of vaccine formulation. The company is headquartered in Bern, Switzerland.
Pevion Biotech Ltd Key Recent Developments
Apr 21, 2011: Pevion Biotech Elects Jean-Paul Prieels To Board
Feb 10, 2011: Pevion Biotech Appoints Didier Hoch As Board Chairman
Sep 07, 2010: Pevion Biotech Appoints Evert Kueppers As New CEO
Apr 26, 2010: Pevion Announces Excellent Preclinical Results For Pev4 Rsv Vaccine Candidate
Mar 22, 2010: Pevion Biotech’s Pev7 Vulvovaginal Candidiasis Vaccine Enters Phase
GlobalData’s Pevion Biotech Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Note: Some sections may be missing if data is unavailable for the company.
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Customers who bought this item also bought
Pevion Biotech Ltd - Product Pipeline Review - Q1 2011
Pevion Biotech Ltd - Product Pipeline Review - Q4 2010
Pevion Biotech Ltd - Product Pipeline Review - H2 2011
Mymetics Corporation - Product Pipeline Review - H2 2011
Mymetics Corporation (MYMX) - Financial and Strategic SWOT Analysis Review
Mymetics Corporation - Product Pipeline Review - Q4 2010
Mymetics Corporation - Product Pipeline Review - Q4 2010
Novavax, Inc. (NVAX) - Financial and Strategic SWOT Analysis Review
Cancer Vaccine Partnering Agreements
Alnylam Pharmaceuticals, Inc - Product Pipeline Review - H2 2011
|
|
|
|
